Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Physiol Pharmacol ; 47(2): 321-8, 1996 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8807559

RESUMO

In the performed experiment the effect of alloxan on insulin secretion by in situ perfused rat pancreas was determined. It was found that alloxan added to the perfusion medium results in a sudden, short-term release of insulin. This effect is independent on the presence of glucose (6.66 mmol/l) in the perfusion medium. Furthermore, it was observed that glucose at 16.66 mmol/l concentration after alloxan perfusion does not stimulate insulin secretion.


Assuntos
Aloxano/farmacologia , Insulina/metabolismo , Pâncreas/efeitos dos fármacos , Animais , Glucose/farmacologia , Secreção de Insulina , Masculino , Pâncreas/metabolismo , Ratos , Ratos Wistar
4.
J Anim Physiol Anim Nutr (Berl) ; 89(11-12): 367-72, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16401187

RESUMO

The effect of gluconasturtiin (GNST) and phenethyl isothiocyanate (PEITC) on some metabolic changes and antioxidative parameters in the rat was tested using different doses of PEITC and duration of GNST or PEITC ingestion. Their effect on antioxidative processes was previously observed, however, their influence on metabolic changes is still poorly characterized. In the performed experiment, the effect of GNST (0.5 mg/kg BW) and PEITC (0.1 mg/kg BW or 0.3 mg/kg BW) administered intragastrically after 4 h or 14 days to growing male rats was studied. PEITC at both doses after 4 h of its administration caused a considerable increase in liver cholesterol and triglyceride content with a concomitant drop in the amount of glycogen. Blood glucose, free fatty acids, phospholipids and total, free, esterified cholesterol as well as cholesterol in high-density lipoprotein were not altered. GNST, at its short-time ingestion, augmented significantly the concentration of triglycerides in blood serum. The compounds tested had no influence on metabolic changes after a longer period of action with the exception of glycogen values in liver, which were substantially augmented by PEITC at both doses. Our trial revealed a lack of GNST and PEITC influence on the content of liver sulphhydryl groups and on glutathione peroxidase and glutathione-S-transferase activities. The only distinct change in the content of malonodialdehyde was observed after short-time action of lower dose of PEITC. Our research showed that the short-term PEITC action constituted a significant factor interfering with liver metabolism. Although PEITC has been repeatedly advocated as very promising anticancer agent, in our experiment, the lower dose of PEITC was revealed as a pro-oxidative substance. These inconsistent properties seem to depend on its dose and time of action.


Assuntos
Anticarcinógenos/farmacologia , Metabolismo Energético/efeitos dos fármacos , Glucosinolatos/farmacologia , Isotiocianatos/farmacologia , Fígado/efeitos dos fármacos , Animais , Anticarcinógenos/administração & dosagem , Antioxidantes , Glicemia/metabolismo , Colesterol/metabolismo , Relação Dose-Resposta a Droga , Glucosinolatos/administração & dosagem , Isotiocianatos/administração & dosagem , Fígado/metabolismo , Glicogênio Hepático/metabolismo , Masculino , Malondialdeído/metabolismo , Oxirredução/efeitos dos fármacos , Ratos , Ratos Wistar , Triglicerídeos/sangue , Triglicerídeos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA